Bristol-Myers Squibb has claimed its second FDA approval in the space of a few days for its immuno-oncology combination of Opdivo and Yervoy, this time in newly diagnosed liver cancer. PD-1 inhibitor ...

AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...

Thanks to robot mops, you no longer need to exert any elbow grease to have a shiny floor. Like robot vacuums, you can now find a dizzying variety of robot mops with a range of features and prices. At ...